André Wyss

Chief Executive Officer at Implenia AG

André Wyss

André Wyss

Chief Executive Officer at Implenia AG

Overview
Career Highlights

Novartis Corporation
Implenia AG

RelSci Relationships

1812

Number of Boards

2

Birthday

1967

Age

53

Relationships
RelSci Relationships are individuals André Wyss likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former President at International Association of Young Lawyers

Relationship likelihood: Strong

Division Head, Alcon at Novartis AG

Relationship likelihood: Strong

Chief Executive Officer at Novartis AG

Relationship likelihood: Strong

Chief Financial Officer at Novartis AG

Relationship likelihood: Strong

Former Chief Executive Officer at Novartis AG

Relationship likelihood: Strong

Chief People & Organization Officer at Novartis AG

Relationship likelihood: Strong

Head of the Novartis Vaccines & Diagnostics Division at Novartis Corporation

Relationship likelihood: Strong

Former President at Allergan USA, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer, Sandoz at Novartis AG

Relationship likelihood: Strong

Group General Counsel of Novartis at Novartis AG

Relationship likelihood: Strong

Paths to André Wyss
Potential Connections via
Relationship Science
You
André Wyss
Chief Executive Officer at Implenia AG
Education
Graduate Degree in Economics
Class of 1995

HWZ University of Applied Sciences for Business Administration is an educational institute. They offer further education courses in MAS, EMBA, and DBA. The company provides educational degrees and courses in fields such as accounting and controlling; banking and finance; digital transformation; human resources and leadership; marketing; communication; real estate management; and more. HWZ University of Applied Sciences for Business Administration was founded in 2005 and is based in Zurich, Switzerland.

Career History
Chief Executive Officer
2018 - Current

Implenia AG engages in the provision of construction services. It operates through the following segments: Development, Buildings, Civil Engineering, and Specialties. The Development segment includes project development. The Buildings segment comprises the design and execution of new constructions and modernization of existing properties. The Civil Engineering segment involves tunneling, foundation engineering, and regional business. The Specialties segment consists Implenia's niche offers. The company was founded on November 4, 2005 and is headquartered in Dietlikon, Switzerland.

Global Head of Business Services & Country President for Switzerland
2014 - 2018

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

President
Prior - 2014

Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by André Wyss. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of André Wyss's profile does not indicate a business or promotional relationship of any kind between RelSci and André Wyss.